Table 6. Distribution of Outcomes by Group and Organism.
Outcome |
Total |
|||
Organism | Amputation | Death | Limb Salvage | |
Group 3 | ||||
MRSA | 3 (42.9%) | 0 | 4 (57.1%) | 7 (100.0%) |
Staphylococcus epidermidis | 0 | 0 | 7 (100.0%) | 7 (100.0%) |
Gram-negative | 5 (55.6%) | 0 | 4 (44.4%) | 9 (100.0%) |
No growth | 0 | 1 (20.0%) | 4 (80.0%) | 5 (100.0%) |
Total | 8 (28.6%) | 1 (3.6%) | 19 (67.9%) | 28 (100.0%) |
Group 4 | ||||
MRSA | 0 | 2 (100.0%) | 2 (100.0%) | |
Staphylococcus epidermidis | 0 | 2 (100.0%) | 2 (100.0%) | |
Gram-negative | 1 (25.0%) | 3 (75.0%) | 4 (100.0%) | |
No growth | 0 | 1 (100.0%) | 1 (100.0%) | |
Total | 1 (11.1%) | 8 (88.9%) | 9 (100.0%) | |
Group 5 | ||||
MRSA | 0 | 0 | 1 (100.0%) | 1 (100.0%) |
Staphylococcus epidermidis | 0 | 0 | 2 (100.0%) | 2 (100.0%) |
Gram-negative | 0 | 1 (100.0%) | 0 | 1 (100.0%) |
No growth | 1 (100.0%) | 0 | 0 | 1 (100.0%) |
Total | 1 (20.0%) | 1 (20.0%) | 3 (60.0%) | 5 (100.0%) |
Data are count (% within organism).
MRSA, methicillin-resistant Staphylococcus aureus.